GSI Sells PerkinElmer Shares
KANATA, Ontario, Dec. 11 -- GSI Lumonics Inc. has completed the sale of 1,398,166 shares of common stock of PerkinElmer Inc. The shares resulted from the conversion of GSI's common stock holdings in Packard BioScience Co., which was acquired by PerkinElmer on Nov. 13. GSI Lumonics initially received 4,495,711 shares of common stock of Packard BioScience Co. as partial consideration for the sale of its Life Sciences business to Packard BioScience in 2000.
The PerkinElmer shares were sold for net proceeds of approximately $38.5 million, at the equivalent price per share of PerkinElmer stock of $27.51, net of all transaction costs. When compared to the original book value of the shares, this transaction creates a nonoperating loss of $0.08 per share after tax.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024